Home
>
National Drug Code (NDC)
>
TENORMIN
TENORMIN - 0310-0107-10 - (Atenolol)
Drug Information of TENORMIN
| Product NDC: | 0310-0107 |
| Proprietary Name: | TENORMIN |
| Non Proprietary Name: | Atenolol |
| Active Ingredient(s): | 25 mg/1 & nbsp; Atenolol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TENORMIN
| Product NDC: | 0310-0107 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018240 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910201 |
Package Information of TENORMIN
| Package NDC: | 0310-0107-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (0310-0107-10) |
NDC Information of TENORMIN
| NDC Code | 0310-0107-10 |
| Proprietary Name | TENORMIN |
| Package Description | 100 TABLET in 1 BOTTLE (0310-0107-10) |
| Product NDC | 0310-0107 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Atenolol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19910201 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | ATENOLOL |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
